1. Home
  2. QURE vs FPF Comparison

QURE vs FPF Comparison

Compare QURE & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$46.42

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

FPF

First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

HOLD

Current Price

$17.67

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
QURE
FPF
Founded
1998
2013
Country
Netherlands
United States
Employees
248
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
QURE
FPF
Price
$46.42
$17.67
Analyst Decision
Buy
Analyst Count
14
0
Target Price
$45.00
N/A
AVG Volume (30 Days)
1.3M
90.9K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
8.08%
EPS Growth
29.67
N/A
EPS
N/A
N/A
Revenue
$13,107,000.00
N/A
Revenue This Year
$126.12
N/A
Revenue Next Year
$200.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.73
$17.21
52 Week High
$71.50
$19.75

Technical Indicators

Market Signals
Indicator
QURE
FPF
Relative Strength Index (RSI) 64.12 33.85
Support Level $21.16 $17.21
Resistance Level $50.47 $18.24
Average True Range (ATR) 2.14 0.18
MACD 0.32 -0.03
Stochastic Oscillator 99.80 6.94

Price Performance

Historical Comparison
QURE
FPF

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

Share on Social Networks: